Picture this: Your doctor orders an imaging test like a chest X-ray in preparation for an upcoming procedure, and the results show a small white spot in the center of your lungs—a pulmonary or lung ...
The genomic test is designed to limit invasive procedures for low-risk patients with suspicious lung nodules. Veracyte, Inc, announced last week that its Percepta test, the first product under a ...
PHILADELPHIA (WPVI) -- Shortness of breath and chest pain could be signs of lung nodules. Most of the time lung nodules are found by accident, or incidentally, during an X-ray or CT scan for something ...
SGMC Health recently launched a Lung Nodule Clinic, a specialized center dedicated to the timely evaluation and treatment of ...
Please provide your email address to receive an email when new articles are posted on . A risk-assessment test that combined levels of plasma proteins and clinical factors accurately determined ...
Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment Company begins making novel, noninvasive test available to limited ...
Non-invasive genomic test is designed to help physicians guide next steps for current and former smokers with lung nodules Lung cancer is the leading cause of cancer death worldwide. Lung nodules are ...
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced publication of an analysis of the ...
A U.S.-based diagnostics company is expanding its presence in lung cancer with the acquisition of assets from a firm based in the U.K. Boulder, Colorado-based Biodesix said Friday that it would buy ...
BOULDER, Colo.--(BUSINESS WIRE)-- Biodesix, Inc. (Nasdaq: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced publication of an analysis of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback